Neurofeedback is Now a Viable Treatment for Huntington’s Disease
Huntington’s disease (HD), also known as Huntington’s chorea, is an inherited disorder that results in the death of brain cells. It eventually leads to severe physical disability (patients lose the ability to walk and talk) and eventually death. Though it is a rare disease (worldwide prevalence of HD is 5–10 cases per 100,000 persons), it’s effects are debilitating and any new therapies to aid in the treatment of it are welcome, as it is considered very difficult to treat.
Researchers at University College London have shown that neurofeedback can increase connectivity in the brains of Huntington’s patients. Their study, “Stimulating neural plasticity with real-time fMRI neurofeedback in Huntington’s disease: A proof of concept study,” appeared in the journal Human Brain Mapping.